The Latest

  • U.S. President Donald Trump watches as Health and Human Services Secretary Robert F. Kennedy Jr. (C) swears in Dr. Mehmet Oz (R) as the Medicare and Medicaid Services Administrator during a ceremony in the Oval Office at the White House on April 18, 2025 in Washington, DC.
    Image attribution tooltip
    Andrew Harnik / Staff via Getty Images
    Image attribution tooltip

    Dr. Oz sworn in as CMS administrator

    During a ceremony at the Oval Office, Mehmet Oz said he would focus on reducing chronic disease, “modernizing” Medicare and Medicaid, and targeting fraud, waste and abuse in government insurance offerings.

  • A person holds a phone, wearing a white patch on their forearm and an insulin pump on their hip.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic gets FDA approval to use Simplera Sync glucose sensor with insulin pumps

    The updated device allows users to pair the sensor with Medtronic’s insulin pumps, and is expected to grow the company’s diabetes business.

  • Two gloved hands hold a flexible yellow strip with small dots on one end.
    Image attribution tooltip
    Courtesy of Precision Neuroscience
    Image attribution tooltip

    Precision Neuroscience receives FDA clearance for brain implant

    The electrode array, which can be implanted for 30 days to map brain activity, is a component of Precision Neuroscience’s planned brain-computer interface system.

  • A view of Boston Scientific's corporate headquarters in Marlborough, Massachusetts, with a clear blue sky in the background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Intuitive, Boston Scientific and Edwards next up in medtech earnings

    Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and competitive dynamics in key markets.

  • Front sign of FDA building
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA cuts outlined in draft HHS budget

    The draft budget would slash FDA’s budget authority, if approved by Congress.

  • man in a navy suit with a red tie sits hands crossed at a desk with a microphone
    Image attribution tooltip
    Kayla Bartkowski via Getty Images
    Image attribution tooltip

    Makary seeks to limit industry’s role in FDA advisory panels

    Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as industry representatives on advisory committees.

    Updated April 18, 2025
    FDA
  • An older patient in a hospital bed wearing a seizure-detecting headset with doctors around him.
    Image attribution tooltip
    Retrieved from Ceribell on April 17, 2025
    Image attribution tooltip

    Ceribell wins FDA nod for algorithm to detect pediatric seizures

    The clearance adds another feature for Ceribell to leverage as it tries to persuade hospitals to switch from conventional EEG systems.

  • The Federal Trade Commission emblem on the Constitution Center in Washington, D.C.
    Image attribution tooltip
    Laurel Deppen/MedTech Dive
    Image attribution tooltip

    Illinois, Minnesota join FTC challenge against $627M Surmodics buyout

    The Illinois attorney general said the deal represents a “troubling trend of wealthy investors attempting to limit competition and innovation.”

  • The entrance to Illumina's San Diego campus.
    Image attribution tooltip
    Courtesy of Illumina
    Image attribution tooltip

    Illumina, Tempus AI partner to drive genomic testing beyond cancer

    The partners plan to build evidence packages that standardize comprehensive genomic profiling and other molecular testing across all major diseases.

  • A person in a blue suit gestures while seated at a conference table.
    Image attribution tooltip
    Andrew Harnik via Getty Images
    Image attribution tooltip

    Budget draft outlines Trump’s plan to slash federal health programs

    An OMB document proposes to cut the HHS budget by roughly one-third as well as eliminate several divisions and programs.

  • A female hematologist analyzes medical samples at a hospital laboratory.
    Image attribution tooltip
    andresr via Getty Images
    Image attribution tooltip
    Deep Dive

    A judge blocked the FDA’s plan to regulate LDTs. What now?

    One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but Congress could still take on the issue.

  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott expects a ‘few hundred million’ in tariff costs in 2025

    CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.

  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s electrophysiology sales dip amid slow Varipulse start

    Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston Scientific in the red-hot pulsed field ablation market.

  • Close up of a machine with several tubes, some of which are red.
    Image attribution tooltip
    saengsuriya13 via Getty Images
    Image attribution tooltip

    DaVita hit by ransomware attack

    The kidney dialysis firm doesn’t have an estimate for how long disruption from the attack will last, though DaVita stressed it’s continuing to provide patient care.

  • an interior shot of johnson and Johnson corporate lobby featuring signage
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip
    Trump tariffs

    J&J expects tariff charge of $400M this year

    CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare giant’s medtech business.

  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards receives CE mark for Sapien M3 mitral valve replacement device

    The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s Mitraclip.

  • A person speaks at a podium in front of a large, out-of-focus painting.
    Image attribution tooltip
    Win McNamee via Getty Images
    Image attribution tooltip
    Trump tariffs

    US launches probe that could set stage for pharma tariffs

    The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S. importing pharmaceuticals and their starting materials.

    Updated April 14, 2025
    FDA
  • Commerce Secretary Howard Lutnick speaks during a cabinet meeting at the White House on March 24, 2025.
    Image attribution tooltip
    Win McNamee via Getty Images
    Image attribution tooltip
    Trump tariffs

    US launches probe into semiconductor imports

    The Section 232 investigation comes ahead of anticipated tariffs on the industry.

  • Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J completes first surgeries with Ottava robot

    Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which was performed in the clinical trial.

  • Trucks drive across the U.S.-Mexico border on Feb. 1, 2025, in San Diego.
    Image attribution tooltip
    Apu Gomes via Getty Images
    Image attribution tooltip
    Trump tariffs

    Tariffs top of mind for medtech firms this earnings season

    GE Healthcare and Medtronic said they are preparing mitigation plans as they assess the potential ramifications of Trump’s tariff policies.

  • A view of Building 1 at Cepheid headquarters in Sunnyvale, California. Cepheid plans to consolidate manufacturing activities at its Sunnyvale headquarters.
    Image attribution tooltip
    The image by Coolcaesar is licensed under CC BY-SA 4.0
    Image attribution tooltip

    Cepheid to lay off 167 people in California

    The company laid off more than 1,300 people in California in 2023 and 2024 as respiratory sales fell from the peak hit during the pandemic.

  • The logos of various pharmaceutical companies are displayed on a cell phone screen.
    Image attribution tooltip
    Robert Way via Getty Images
    Image attribution tooltip
    Trump tariffs

    Pharma bosses face down investor angst on tariffs, HHS chaos

    As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S. tariffs on their products.

  • A stethoscope rests on a pile of $100 bills.
    Image attribution tooltip
    Foremniakowski via Getty Images
    Image attribution tooltip

    Late-stage digital health funding rebounds in Q1: Rock Health

    The median deal size for late-stage funding rounds was $105 million, nearly double the $55 million check size across 2024.

  • A surgeon in blue scrubs and a facemask examines a da Vinic robotic surgery system in an operating room.
    Image attribution tooltip
    Retrieved from Intuitive Surgical on April 11, 2025
    Image attribution tooltip

    Intuitive wins FDA clearance for single-port robotic surgery stapler

    CFO Jamie Samath said in January that the stapler clearance would trigger the start of “broad commercial efforts” for the single-port system.

  • The cab of a semi truck appears blurry while driving past a stack of shipping containers in the background.
    Image attribution tooltip
    Spencer Platt / Staff via Getty Images
    Image attribution tooltip
    Trump tariffs

    Tariff turmoil: Hospitals, device makers welcome pause, but fear long-term pain

    Healthcare providers and medtech companies still face pressure to find ways to offset potential supply chain shocks despite the latest about-face in President Donald Trump’s tariff wars.